TL;DR
Get school and study supplies delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A Nature paper by Vadim Gladyshev and colleagues and a recent Cell paper from Juan Carlos Izpisua Belmonte’s team examine how cells lose stable identity as they age. The work complements damage-based explanations of aging, but does not establish how much each process contributes or show that the changes can be safely reversed in people.
A Nature paper by Vadim Gladyshev and colleagues at Harvard, alongside a recent Cell paper from Juan Carlos Izpisua Belmonte’s team at Altos Labs, advances a model in which aging involves cells losing some of the epigenetic controls that maintain their specialized identities. The findings add a possible process to the established focus on accumulated cellular damage, but the papers do not settle how much either process drives aging or establish a treatment that reverses it in people.
Cells share nearly the same DNA, but use different patterns of gene regulation to perform distinct jobs. Those patterns are shaped in part by epigenetic structures in the nucleus, including chromatin organization. The Nature study describes a layered system: rapid responses to stress, intermediate changes in cell state, and slower controls that help preserve a cell’s identity over time.
The paper links the slow regulatory layer to PRC2, a molecular complex involved in maintaining epigenetic organization. The account in Ground Truths says the researchers connect changes in PRC2-associated regions with measurements used by epigenetic clocks. That provides a proposed interpretation of what some clock signals reflect; it does not mean that every clock directly measures all aspects of cell identity or that the mechanism has been proven to explain aging on its own.
The Cell paper examines mesenchymal drift: shifts in which specialized cells take on features associated with mesenchymal cells, including fibroblasts. The source report says this pattern was observed across 46 tissue types and associated with disease progression and poorer outcomes. It describes a possible feedback loop in which activated fibroblasts promote further scarring and extracellular-matrix production. Those observations indicate a relationship, not proof that drift independently causes every disease cited.
How Identity Loss Could Affect Tissues
The proposed model gives researchers a way to connect epigenetic aging with changes visible in tissues, such as scarring and inflammation. If specialized cells become less stable and move toward other states, that could help explain why aging tissues lose function and why fibrotic changes appear alongside several age-related conditions.
For readers, the work matters because it broadens the discussion beyond the idea that cells simply accumulate damage. It suggests that the systems preserving cell identity may also weaken, potentially interacting with damage and chronic inflammation. The potential relevance to cancer and diseases such as atherosclerosis, macular degeneration, and Alzheimer’s disease is a research direction described by the source, not evidence that one mechanism accounts for all of them.
The findings may also guide future work on interventions that preserve cell identity or limit harmful state changes. But a model that helps organize evidence is not itself a therapy: the reports do not show that changing PRC2 or reversing mesenchymal drift is safe, effective, or able to extend human lifespan.
As an affiliate, we earn on qualifying purchases.
From Damage to Cell-State Drift
Much aging research has emphasized the accumulation of cellular damage over time. The new papers do not discard that account. Instead, they add loss of cell identity as another possible route through which tissues age, while leaving open whether the two processes are independent, connected, or different in importance across tissues.
The Nature paper uses the idea of an epigenetic landscape: differentiated cells occupy stable states maintained by regulatory constraints. In the model described by Ground Truths, aging weakens those constraints, making cell identity less stable. The source attributes a role in maintaining that structure to PRC2 and suggests chronic inflammation can interfere with the system. The degree to which that sequence applies across people and tissues remains an empirical question.
The Cell study focuses on the consequences of cell-state changes, especially the move toward mesenchymal features. The report links this drift to fibrosis and disease-associated tissue changes. Together, the papers offer a proposed connection between regulatory erosion and tissue-level outcomes; they are complementary studies, not a single demonstration of a complete causal chain.
“We don’t know the relative contribution or interdependence of these 2 models in the aging process.”
— Ground Truths report
As an affiliate, we earn on qualifying purchases.
Causation and Reversal Remain Open
The two studies do not establish how much cell-identity loss contributes to human aging relative to accumulated damage, or whether the mechanisms reinforce one another. The source report also does not provide enough study details to assess the methods, participant or sample composition, or the strength of evidence for each proposed link.
It remains unclear whether mesenchymal drift is a cause of particular diseases, a consequence of tissue damage, or both. The reported presence of a pattern across 46 tissue types and associations with disease outcomes do not by themselves establish causation. The suggested role of chronic inflammation in disrupting PRC2, and the persistence of epigenetic changes after inflammation resolves, also require careful interpretation in light of the underlying studies.
Most importantly, the material describes a biological model and possible intervention targets, not a demonstrated way to restore youthful cell identity in humans. It does not establish that caloric restriction, PRC2-related interventions, or other approaches can safely prevent or reverse aging-related drift.
As an affiliate, we earn on qualifying purchases.
Testing Targets in Living Systems
The next research step is to test whether the proposed links hold across specific tissues and over time, and to distinguish causal changes from correlations. Researchers will also need to determine how cell-identity measures relate to existing epigenetic clocks and to functional outcomes, rather than treating a clock signal as direct proof of a mechanism.
Intervention studies would need to show whether preserving epigenetic controls or limiting mesenchymal drift improves tissue function, and whether any benefits come with harmful effects. The supplied report mentions caloric restriction as a possible influence on pathways related to PRC2, but offers no evidence here that it reverses identity loss or constitutes a clinical recommendation. No specific follow-up dates or human trial milestones are provided.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the two papers propose?
They explore whether aging involves loss of stable cell identity, alongside accumulated cellular damage, and whether some cells drift toward mesenchymal states associated with scarring.
Does cell identity loss replace the damage model of aging?
No. The source report says the relative contributions and possible interaction of the two models are unknown. The papers add a framework rather than disprove damage-based explanations.
What is mesenchymal drift?
It describes specialized cells taking on features associated with mesenchymal cells such as fibroblasts. The reported work links this pattern with tissue scarring and disease-related changes, but association alone does not prove causation.
Do the studies show that aging can be reversed in people?
No. The reports identify possible mechanisms and research targets, but do not establish a safe, effective human treatment that reverses cell-identity loss or extends lifespan.
Source: hn
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
